Source:http://linkedlifedata.com/resource/pubmed/id/15536155
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2005-2-8
|
pubmed:abstractText |
Various matrix metalloproteinases (MMPs) participate in the menstrual breakdown of the human endometrium. MMP-9/gelatinase B is proposed as a major factor because it degrades many extracellular matrix constituents, including in the vasculature. Although globally under ovarian steroids control, endometrial MMP-9 seems expressed differently than other MMPs, and conflicting publications prevent a clear understanding of its regulation. We therefore quantified MMP-9 expression in the cycling human endometrium, defined its localization, and analyzed its regulation by estradiol and progesterone and by LEFTY-A/endometrial bleeding-associated factor in explant cultures. In fresh tissues, a major increase in MMP-9 mRNA expression occurred at menstruation, after a larger increase in LEFTY-A mRNA. MMP-9 was immunodetected in all cell types throughout the cycle, especially in foci of stromal cells during menstruation. MMP-9 synthesis by these cells was confirmed in cultured explants. In proliferative explants, ovarian steroids slightly decreased MMP-9 mRNA. They had no consistent effect on MMP-9 release in culture medium but strongly inhibited proMMP-9 activation. Addition of recombinant LEFTY-A to explants induced MMP-9 in most samples, a response prevented by ovarian steroids. We propose that endometrial MMP-9 activity is overall controlled by the ovarian steroids and locally adjusted through a network of modulators, including LEFTY-A.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/DNA Primers,
http://linkedlifedata.com/resource/pubmed/chemical/LEFTY1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Left-Right Determination Factors,
http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 9,
http://linkedlifedata.com/resource/pubmed/chemical/Progesterone,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0021-972X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
90
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1001-11
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:15536155-Base Sequence,
pubmed-meshheading:15536155-Biopsy,
pubmed-meshheading:15536155-Cells, Cultured,
pubmed-meshheading:15536155-DNA Primers,
pubmed-meshheading:15536155-Endometrium,
pubmed-meshheading:15536155-Female,
pubmed-meshheading:15536155-Gene Expression Regulation, Enzymologic,
pubmed-meshheading:15536155-Humans,
pubmed-meshheading:15536155-Left-Right Determination Factors,
pubmed-meshheading:15536155-Matrix Metalloproteinase 9,
pubmed-meshheading:15536155-Menstrual Cycle,
pubmed-meshheading:15536155-Ovary,
pubmed-meshheading:15536155-Polymerase Chain Reaction,
pubmed-meshheading:15536155-Progesterone,
pubmed-meshheading:15536155-RNA, Messenger,
pubmed-meshheading:15536155-Transforming Growth Factor beta
|
pubmed:year |
2005
|
pubmed:articleTitle |
Regulation of matrix metalloproteinase-9/gelatinase B expression and activation by ovarian steroids and LEFTY-A/endometrial bleeding-associated factor in the human endometrium.
|
pubmed:affiliation |
Cell Biology Unit, Christian de Duve Institute of Cellular Pathology, Université Catholique de Louvain, B-1200 Brussels, Belgium.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|